Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets
- PMID: 17289931
- DOI: 10.1152/physiol.00033.2006
Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets
Abstract
Cardiac hypertrophy leads to heart failure, and both conditions can ultimately prove lethal. Here, traditional and novel mechanisms relating hypertrophy and heart failure are described at the physiological, cellular, and molecular levels. The rational application of these mechanistic considerations to therapeutics targeting hypertrophy and heart failure is discussed.
Similar articles
-
Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.Clin Exp Pharmacol Physiol. 2007 Apr;34(4):255-62. doi: 10.1111/j.1440-1681.2007.04585.x. Clin Exp Pharmacol Physiol. 2007. PMID: 17324134 Review.
-
Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure.Circ Res. 2014 Jan 31;114(3):565-71. doi: 10.1161/CIRCRESAHA.114.300507. Circ Res. 2014. PMID: 24481846 Review.
-
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets.Arch Toxicol. 2015 Sep;89(9):1401-38. doi: 10.1007/s00204-015-1477-x. Epub 2015 Feb 24. Arch Toxicol. 2015. PMID: 25708889 Review.
-
Apoptotic and non-apoptotic programmed cardiomyocyte death in ventricular remodelling.Cardiovasc Res. 2009 Feb 15;81(3):465-73. doi: 10.1093/cvr/cvn243. Epub 2008 Sep 8. Cardiovasc Res. 2009. PMID: 18779231 Free PMC article. Review.
-
New molecular mechanism in diastolic heart failure.Circulation. 2006 Apr 25;113(16):1922-5. doi: 10.1161/CIRCULATIONAHA.106.620765. Circulation. 2006. PMID: 16636184 No abstract available.
Cited by
-
Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction.Circ Res. 2016 Jun 10;118(12):1918-1929. doi: 10.1161/CIRCRESAHA.116.308688. Epub 2016 Apr 28. Circ Res. 2016. PMID: 27126808 Free PMC article.
-
OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.Clin Exp Pharmacol Physiol. 2019 Aug;46(8):743-751. doi: 10.1111/1440-1681.13101. Epub 2019 May 23. Clin Exp Pharmacol Physiol. 2019. PMID: 31063653 Free PMC article.
-
Autophagy, redox signaling, and ventricular remodeling.Antioxid Redox Signal. 2009 Aug;11(8):1975-88. doi: 10.1089/ars.2009.2524. Antioxid Redox Signal. 2009. PMID: 19327038 Free PMC article. Review.
-
Cardiac damage in athlete's heart: When the "supernormal" heart fails!World J Cardiol. 2017 Jun 26;9(6):470-480. doi: 10.4330/wjc.v9.i6.470. World J Cardiol. 2017. PMID: 28706583 Free PMC article. Review.
-
Overexpression of FNTB and the activation of Ras induce hypertrophy and promote apoptosis and autophagic cell death in cardiomyocytes.J Cell Mol Med. 2020 Aug;24(16):8998-9011. doi: 10.1111/jcmm.15533. Epub 2020 Jun 24. J Cell Mol Med. 2020. PMID: 32579303 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical